What is the registration number for STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION."?

STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." is registered under USPTO registration number 8482313.

STR

USPTO Trademark Record

REGISTERED

STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION."

Q: Who owns the STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." trademark?

The STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." trademark is owned by STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC.

Q: What class is the STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." trademark registered in?

The STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION."?

The USPTO serial number for STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." is 99522920.

SN 99522920·Reg 8482313·Filed Dec 01, 2025

Owner STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." (Serial No. 99522920), Registration No. 8482313, is a registered US trademark filed on Dec 01, 2025 by STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: October 06, 2032

Mark Intelligence

STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." (Reg. #8482313) is a registered US trademark that has been protecting its owner, STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC, since 2025. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 01, 2025

SERIAL

99522920

REG#

8482313

REGISTERED

Oct 06, 2026

Owner

Applicant

STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC

Entity

LLC

State

Address

210 Gray Rd, Templeton, MA, 01468

Country

Attorney

NameMichael McGovern

Law firm

Michael McGovern LZ Legal Services, LLC

Docket

E584948480

Address

2828 N Central Ave, PMB #1510, Phoenix, AZ 85004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 01, 2025

Serial Number99522920

Registration No.8482313

Registration DateOct 06, 2026

Status DateOct 06, 2026

Published for OppositionAug 18, 2026

Mark TypeDesign with words

Attorney DocketE584948480

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 24, 2025

First use in commerce: Oct 24, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

REGISTERED-PRINCIPAL REGISTER

Oct 06, 2026

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Aug 18, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 18, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 12, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 20, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 22, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 22, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 22, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 13, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 13, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 13, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 02, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 27, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 27, 2026

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Dec 01, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Dec 01, 2025

APPLICATION FILING RECEIPT MAILED

STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION."

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Michael McGovern

Resources

Company